NO20024239L - Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe - Google Patents

Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe

Info

Publication number
NO20024239L
NO20024239L NO20024239A NO20024239A NO20024239L NO 20024239 L NO20024239 L NO 20024239L NO 20024239 A NO20024239 A NO 20024239A NO 20024239 A NO20024239 A NO 20024239A NO 20024239 L NO20024239 L NO 20024239L
Authority
NO
Norway
Prior art keywords
group
alkyl
oxidizing
alkoxy
sulfoxide
Prior art date
Application number
NO20024239A
Other languages
English (en)
Norwegian (no)
Other versions
NO20024239D0 (no
Inventor
Ramon Berenguer Maimo
Julio Campo Pardo
Laura Coppi
Original Assignee
Esteve Quimica Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Esteve Quimica Sa filed Critical Esteve Quimica Sa
Publication of NO20024239D0 publication Critical patent/NO20024239D0/no
Publication of NO20024239L publication Critical patent/NO20024239L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00Preparation of sulfones; Preparation of sulfoxides
    • C07C315/02Preparation of sulfones; Preparation of sulfoxides by formation of sulfone or sulfoxide groups by oxidation of sulfides, or by formation of sulfone groups by oxidation of sulfoxides

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
NO20024239A 2000-03-13 2002-09-05 Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe NO20024239L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200000595A ES2163372B1 (es) 2000-03-13 2000-03-13 Procedimiento de oxidacion de un grupo tioeter a sulfoxido.
PCT/ES2001/000088 WO2001068594A1 (es) 2000-03-13 2001-03-08 Procedimiento de oxidacion de un grupo tioeter a sulfoxido

Publications (2)

Publication Number Publication Date
NO20024239D0 NO20024239D0 (no) 2002-09-05
NO20024239L true NO20024239L (no) 2002-09-05

Family

ID=8492674

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024239A NO20024239L (no) 2000-03-13 2002-09-05 Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe

Country Status (16)

Country Link
US (1) US6603009B2 (https=)
EP (1) EP1270555B1 (https=)
JP (1) JP5041646B2 (https=)
KR (1) KR100657094B1 (https=)
CN (1) CN1229341C (https=)
AT (1) ATE274492T1 (https=)
AU (2) AU3745201A (https=)
CA (1) CA2402635C (https=)
DE (1) DE60105139T2 (https=)
ES (2) ES2163372B1 (https=)
HU (1) HUP0301885A2 (https=)
MX (1) MXPA02008961A (https=)
NO (1) NO20024239L (https=)
NZ (1) NZ521071A (https=)
PT (1) PT1270555E (https=)
WO (1) WO2001068594A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1970374A1 (en) 2001-02-02 2008-09-17 Teva Pharmaceutical Industries Ltd. Process for the production of substituted 2-(pyridin-2-ylmethylsulfinyl)-1H-benzimidazoles
KR100464174B1 (ko) * 2002-03-06 2005-01-03 코오롱유화주식회사 설피닐 벤즈이미다졸 유도체의 제조방법
US6909004B2 (en) 2002-08-21 2005-06-21 Teva Pharmaceutical Industries Ltd. Method for the purification of lansoprazole
EP1465890B1 (en) 2002-11-18 2007-04-04 Teva Pharmaceutical Industries Ltd. Stable lansoprazole containing more than 500 ppm, up to about 3,000 ppm water and more than 200 ppm, up to about 5,000 ppm alcohol
CA2510849A1 (en) 2002-12-19 2004-07-08 Teva Pharmaceutical Industries Ltd Solid states of pantoprazole sodium, processes for preparing them and processes for preparing known pantoprazole sodium hydrates
EP1485373A1 (en) 2003-02-05 2004-12-15 Teva Pharmaceutical Industries Limited Method of stabilizing lansoprazole
WO2004111029A2 (en) * 2003-06-10 2004-12-23 Teva Pharmaceutical Industries Ltd. Process for preparing 2-[(pyridinyl)methyl]sulfinyl-substituted benzimidazoles and novel chlorinated derivatives of pantoprazole
WO2006013960A1 (ja) 2004-08-06 2006-02-09 Eisai R & D Management Co., Ltd. ベンズイミダゾール誘導体とアミンとの塩およびその製造方法
PL1802584T3 (pl) 2004-10-11 2010-03-31 Ranbaxy Laboratories Ltd Sposób wytwarzania podstawionych sulfotlenków
KR100771659B1 (ko) 2005-03-23 2007-10-30 주식회사 카이로제닉스 판토프라졸 및 그 중간체의 제조방법
CN1919844B (zh) * 2006-09-01 2010-05-12 武汉工程大学 水相氧化合成兰索拉唑的方法
WO2009066309A2 (en) * 2007-07-12 2009-05-28 Cadila Healthcare Limited Process for preparation of omeprazole
WO2009010937A1 (en) * 2007-07-17 2009-01-22 Ranbaxy Laboratories Limited Process for the preparation op pantoprazole sodium and pantoprazole sodium sesquihydrate
CN102161633A (zh) * 2011-02-22 2011-08-24 苏州科同生物医药科技有限公司 亚砜类有机化合物的制备方法
CN103044399B (zh) * 2011-10-12 2014-08-06 北大方正集团有限公司 一种雷贝拉唑及其钠盐的制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2026761A6 (es) * 1990-10-31 1992-05-01 Genesis Para La Investigacion Procedimiento de obtencion del omeprazol.
ES2036948B1 (es) * 1991-11-21 1994-09-01 Genesis Para La Investigacion Procedimiento de obtencion de compuestos derivados de piridina.
ES2060541B1 (es) * 1993-02-26 1995-11-16 Vinas Lab Nuevo procedimiento para la sintesis de un derivado de 2-(2-piridilmetilsufinil) bencimidazol, y nuevos productos intermedios obtenidos con el mismo.
US6313303B1 (en) 1997-07-11 2001-11-06 Eisai Co., Ltd. Process for the preparation of pyridine derivatives
US6437189B1 (en) * 1997-12-12 2002-08-20 Bayer Corporation Synthesis of sulfoxides via selective oxidation of sulfides with a perborate or a percarbonate
ES2185459B1 (es) * 2000-10-02 2003-12-16 Dinamite Dipharma Spa Procedimiento para la obtencion de pantoprazol y compuestos intermedios para el mismo.

Also Published As

Publication number Publication date
CA2402635A1 (en) 2001-09-20
ES2163372B1 (es) 2003-05-01
CN1418188A (zh) 2003-05-14
KR20030007461A (ko) 2003-01-23
JP2003527370A (ja) 2003-09-16
JP5041646B2 (ja) 2012-10-03
CN1229341C (zh) 2005-11-30
NO20024239D0 (no) 2002-09-05
ES2163372A1 (es) 2002-01-16
ATE274492T1 (de) 2004-09-15
AU3745201A (en) 2001-09-24
HUP0301885A2 (hu) 2003-09-29
AU2001237452B9 (en) 2005-01-27
EP1270555A1 (en) 2003-01-02
US20030028030A1 (en) 2003-02-06
MXPA02008961A (es) 2004-10-15
EP1270555B1 (en) 2004-08-25
NZ521071A (en) 2004-05-28
KR100657094B1 (ko) 2006-12-12
US6603009B2 (en) 2003-08-05
PT1270555E (pt) 2005-01-31
ES2227145T3 (es) 2005-04-01
DE60105139D1 (de) 2004-09-30
WO2001068594A1 (es) 2001-09-20
DE60105139T2 (de) 2005-09-15
AU2001237452B2 (en) 2005-01-13
CA2402635C (en) 2008-07-08

Similar Documents

Publication Publication Date Title
NO20024239L (no) Fremgangsmåte ved oksidasjon av en tioetergruppe til en sulfoksidgruppe
ZA200309887B (en) Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
EA200200481A1 (ru) Способ получения производных 4-трифторметилсульфинилпиразола
ID21450A (id) S-oksida dan s,s-dioksida tetrahidrotiopiran pheniloksazolidinon
DK1040108T3 (da) Orthoanthranilamidderivater som antikoagulanter
ATE260255T1 (de) 5-oxo-pyrrolidine-2-carbonsäure- hydroxamidderivate
ATE517663T1 (de) Photostabile organische sonnenschutzverbindungen mit antioxidationseigenschaften und daraus gewonnene zusammensetzungen
ATE435848T1 (de) Stabilisierte zusammensetzungen einer wässrigen lösung von reduziertem coenzym q
DE60233664D1 (de) Verfahren zur herstellung von pyridinverbindungen
ATE408598T1 (de) Bicyclische verbindung
DE60015390D1 (de) Antidiabetische thiazolidindione und ihre herstellung
DE50105075D1 (de) Oxidationsfärbemittel
EP1357124A4 (en) HETEROCYCLIC COMPOUNDS AND COMPOSITIONS IMPROVING CEREBRAL FUNCTIONS CONTAINING THESE AS ACTIVE INGREDIENTS
BRPI0411664A (pt) composição oral antiplaca aquosa estável
BR0009453B1 (pt) processo para a preparação de um composto.
DK1156058T3 (da) Fremgangsmåde til fremstilling af (E,Z) 3-(2-aminoethoxyimino)-androstan-6,17-dion og analoger deraf
DK0452926T3 (da) 5-Aryl-4-alkyl-3H-1,2,4-triazol-3-thioner, der kan anvendes som hukommelsesforbedrende midler
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
DE60130615D1 (de) Verfahren zur Herstellung von 6-Alpha-Fluoro,9,11-Beta-Epoxy-Steroide
NO20030058D0 (no) 3-hydroksymetyl-benzo(B)tiofenderivater og fremgangsmåter for fremstillingderav
DK0979822T3 (da) Fremgangsmåde til fremstilling af 2-carbamoyl-pyridiner
BR0211519A (pt) Derivados do ácido butìrico
ATE350069T1 (de) Potenziertes und stabilisiertes desinfektionsmittel mit bakterizider und viruzider wirkung
BR0210201A (pt) Composição
EP1607390A4 (en) pyrazole